| Human iPSC-derived natural killer cells engineered with chimeric antigen receptors enhance anti-tumor activity Y Li, DL Hermanson, BS Moriarity, DS Kaufman Cell stem cell 23 (2), 181-192. e5, 2018 | 912 | 2018 |
| Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells M Daher, R Basar, E Gokdemir, N Baran, N Uprety, AK Nunez Cortes, ... Blood, The Journal of the American Society of Hematology 137 (5), 624-636, 2021 | 230 | 2021 |
| Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells H Shaim, M Shanley, R Basar, M Daher, J Gumin, DB Zamler, N Uprety, ... The Journal of clinical investigation 131 (14), 2021 | 189 | 2021 |
| Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial D Marin, Y Li, R Basar, H Rafei, M Daher, J Dou, V Mohanty, M Dede, ... Nature medicine 30 (3), 772-784, 2024 | 154 | 2024 |
| KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape Y Li, R Basar, G Wang, E Liu, JS Moyes, L Li, LN Kerbauy, N Uprety, ... Nature medicine 28 (10), 2133-2144, 2022 | 107 | 2022 |
| CAR‐NK cells: the next wave of cellular therapy for cancer M Daher, L Melo Garcia, Y Li, K Rezvani Clinical & Translational Immunology 10 (4), e1274, 2021 | 98 | 2021 |
| Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering L Li, V Mohanty, J Dou, Y Huang, PP Banerjee, Q Miao, JG Lohr, ... Science Advances 9 (30), eadd6997, 2023 | 60 | 2023 |
| Concise review: human pluripotent stem cells to produce cell-based cancer immunotherapy H Zhu, YS Lai, Y Li, RH Blum, DS Kaufman Stem Cells 36 (2), 134-145, 2018 | 48 | 2018 |
| GMP-compliant universal antigen presenting cells (uAPC) promote the metabolic fitness and antitumor activity of armored cord blood CAR-NK cells E Liu, SOT Ang, L Kerbauy, R Basar, I Kaur, M Kaplan, L Li, Y Tong, ... Frontiers in immunology 12, 626098, 2021 | 43 | 2021 |
| Large-scale GMP-compliant CRISPR-Cas9–mediated deletion of the glucocorticoid receptor in multivirus-specific T cells R Basar, M Daher, N Uprety, E Gokdemir, A Alsuliman, E Ensley, G Ozcan, ... Blood advances 4 (14), 3357-3367, 2020 | 35 | 2020 |
| A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation L Li, H Chen, D Marin, Y Xi, Q Miao, J Lv, PP Banerjee, H Shaim, M Daher, ... Blood Advances 3 (23), 4117-4130, 2019 | 35 | 2019 |
| Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy R Basar, N Uprety, E Ensley, M Daher, K Klein, F Martinez, F Aung, ... Cell Reports 36 (3), 2021 | 30 | 2021 |
| Metabolic reprogramming of GMP grade cord tissue derived mesenchymal stem cells enhances their suppressive potential in GVHD M Mendt, M Daher, R Basar, M Shanley, B Kumar, FL Wei Inng, S Acharya, ... Frontiers in immunology 12, 631353, 2021 | 23 | 2021 |
| Inhibition of antiestrogen-promoted pro-survival autophagy and tamoxifen resistance in breast cancer through vitamin D receptor Y Li, KL Cook, W Yu, L Jin, KB Bouker, R Clarke, L Hilakivi-Clarke Nutrients 13 (5), 1715, 2021 | 21 | 2021 |
| Next‐generation chimeric antigen receptors for T‐and natural killer‐cell therapies against cancer Y Li, K Rezvani, H Rafei Immunological reviews 320 (1), 217-235, 2023 | 19 | 2023 |
| Isoform expression patterns of EPHA10 protein mediate breast cancer progression by regulating the E-Cadherin and β-catenin complex Y Li, L Jin, F Ye, Q Ma, Z Yang, D Liu, J Yang, D Ma, Q Gao Oncotarget 8 (18), 30344, 2017 | 19 | 2017 |
| Sema4d is required for the development of the hindbrain boundary and skeletal muscle in zebrafish J Yang, Z Zeng, J Wei, L Jiang, Q Ma, M Wu, X Huang, S Ye, Y Li, D Ma, ... Biochemical and biophysical research communications 433 (2), 213-219, 2013 | 11 | 2013 |
| Primary screening for breast diseases among 17618 women in Wufeng area, a region with high incidence of cervical cancer in China Q Zhang, D Liu, C Hang, T Hu, J Shen, M Hu, R Yang, Z Chen, Z Lai, ... Journal of Huazhong University of Science and Technology [Medical Sciences …, 2012 | 10 | 2012 |
| Activated B cells suppress T-cell function through metabolic competition N Imahashi, R Basar, Y Huang, F Wang, N Baran, PP Banerjee, J Lu, ... Journal for immunotherapy of cancer 10 (12), e005644, 2022 | 9 | 2022 |
| CD28 costimulation augments CAR signaling in NK cells via the LCK/CD3ζ/ZAP70 signaling axis S Acharya, R Basar, M Daher, H Rafei, P Li, N Uprety, E Ensley, ... Cancer discovery 14 (10), 1879-1900, 2024 | 8 | 2024 |
